沃森生物

- 300142

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
沃森生物(300142) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入59,975.36411,377.23315,804.44216,767.1383,326.74
营业收入59,975.36411,377.23315,804.44216,767.1383,326.74
二、营业总成本46,214.98315,221.33232,086.84152,614.4466,153.95
营业成本11,351.8859,755.6245,126.3627,256.6712,484.71
营业税金及附加417.343,202.602,537.271,971.251,161.88
销售费用21,045.57151,957.55114,335.2478,304.6530,503.44
管理费用6,178.5629,762.3718,062.6512,089.545,823.34
财务费用-1,480.44-7,099.33-5,318.92-3,526.25-1,710.24
研发费用8,702.0677,642.5357,344.2336,518.5917,890.82
资产减值损失----------
公允价值变动收益-8,481.79-23,475.01-6,738.89-1,765.29-119.29
投资收益8.68711.45629.46632.84-26.77
其中:对联营企业和合营企业的投资收益8.6838.21-43.78-40.40-21.57
汇兑收益----------
三、营业利润5,964.9261,396.6177,931.1663,205.5521,447.86
加:营业外收入0.0193.5193.3291.324.88
减:营业外支出239.601,592.47602.38494.49379.55
其中:非流动资产处置损失----------
四、利润总额5,725.3259,897.6577,422.1162,802.3821,073.19
减:所得税费用1,894.108,765.147,699.176,547.461,242.79
五、净利润3,831.2251,132.5169,722.9456,254.9119,830.40
归属于母公司所有者的净利润1,412.7541,939.0255,337.6545,523.9817,199.09
少数股东损益2,418.479,193.4914,385.2910,730.932,631.31
六、每股收益
基本每股收益(元/股)0.00880.26210.34580.28440.1074
稀释每股收益(元/股)0.00880.26210.34580.28440.1074
七、其他综合收益----------
八、综合收益总额3,831.2251,132.5169,722.9456,254.9119,830.40
归属于母公司所有者的综合收益总额1,412.7541,939.0255,337.6545,523.9817,199.09
归属于少数股东的综合收益总额2,418.479,193.4914,385.2910,730.932,631.31
下载全部历史数据到excel中 返回页顶